Ebit Veränderung Datum
Alterity Therapeutics Limited AUD -8.07M 302.4K 2025-12
Ardelyx USD -30.68M 35.78M 2026-03
aTyr Pharma USD -121.47K 24.59M 2026-03
Biogen USD 419.5M 663.3M 2026-09
Bristol-Myers Squibb USD 255M 44M 2026-09
Cipla INR 10.43B 1.55B 2026-09
Clal Biotechnology ILS -5.44M 3.76M 2022-12
Compugen USD -9.02M 65.06M 2026-03
CSL USD 2.64B 116M 2025-12
Curis USD -11.52M 3.64M 2026-03
GlaxoSmithKline GBP 2.86B 251M 2026-09
Grifols EUR 320.55M 91.01M 2025-12
Lakefront Biotherapeutics EUR -43.51M 20.19M 2026-06
Novartis USD 4.73B 549M 2026-06
Roche Holding CHF 11.46B 1.91B 2026-06
United Therapeutics USD 375.6M 49.8M 2026-06